check_circleStudy Completed

Hypertension

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment

Trial purpose

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment

Key Participants Requirements

Sex

Both

Age

18 Years
  • - Patients over 18 years of age
    - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
    - Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)

    Inclusion criteria for the control arm (treated by ACEi):
    - Patients over 18 years of age
    - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
    - Patients, who tolerate ACEi treatment

  • - Cholestasis, severe hepatic insufficiency
    - Allergy to telmisartan
    - Gravidity or lactation

    Exclusion criteria for the arm of patient treated by ACEi:
    - Cholestasis, severe hepatic insufficiency
    - Allergy to ACEi
    - Gravidity or lactation

Trial summary

Enrollment Goal
3114
Trial Dates
December 2007 - June 2008
Phase
N/A
Could I Receive a placebo
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Location, Slovakia
Completed
Many Locations, Romania

Primary Outcome

  • To evaluate efficacy and safety of telmisartan in patients with arterial hypertension, who do not tolerate ACEI treatment
    date_rangeTime Frame:
    1 year
    enhanced_encryption
    Safety Issue:
    Yes

Trial design

Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A